|Plasmid DNA Manufacturing Market Size Worth $1.51 Billion by 2030: Grand View Research, Inc.|
|By: PR Newswire Association LLC. - 05 Oct 2022||Back to overview list
SAN FRANCISCO, Oct. 5, 2022 /PRNewswire/ -- The global plasmid DNA manufacturing market size is expected to reach USD 1.51 billion by 2030, registering a CAGR of 13.71% over the forecast period, according to a new report by Grand View Research, Inc. The rising prevalence of chronic diseases, combined with the wide application scope of plasmid DNA in the healthcare industry is expected to drive the industry growth. Plasmid DNA can be used directly for therapeutic applications, such as the production of vaccine antigens or gene therapy. Moreover, it can be utilized for various research purposes, such as gene cloning, gene mapping, etc. The rising number of patients choosing gene therapy is expected to drive industry growth in the coming years.
Read 150 page full market research report for more Insights, "Plasmid DNA Manufacturing Market Size, Share & Trends Analysis Report By Disease (Cancer, Infectious Diseases), By Grade (R&D, GMP), By Application, By Development Phase, And Segment Forecasts, 2022 - 2030", published by Grand View Research.
Plasmid DNA Manufacturing Market Growth & Trends
According to clinicaltrials.gov, the number of cell & gene therapies across global pipeline programs (Phase I to Phase III trials) increased from 289 in 2018 to 327 in 2022. Furthermore, the U.S. FDA provides constant support for innovations in the advanced therapy arena via several policies concerning product manufacturing. With increased cell and gene therapy products, the industry will see an increased need for manufacturing plasmid DNA on a larger scale. The COVID-19 pandemic is anticipated to positively impact industry growth. For instance, in September 2021, India approved the first COVID-19 DNA vaccine. It is the world's first COVID-19 DNA vaccine manufactured in partnership with DBT-BIRAC as part of Mission COVID Suraksha.
Circular DNA is used in India's ZyCoV-D vaccination to protect against COVID-19 infection. Furthermore, key entities in the global industry are undertaking various strategic initiatives to strengthen their market presence, which is also expected to propel growth. For instance, in June 2022, BioCina announced the expansion of the production of plasmid DNA in a new dedicated GMP suite to its offering of CDMO services. The suite has a single-use fermentation capacity of up to 300 L and appropriately scaled downstream processing machinery.
Plasmid DNA Manufacturing Market Segmentation
Grand View Research has segmented the global plasmid DNA manufacturing market based on grade, development phase, application, disease, and region:
Plasmid DNA Manufacturing Market - Grade Scope Outlook (Revenue, USD Million, 2018 - 2030)
Plasmid DNA Manufacturing Market - Development Phase Scope Outlook (Revenue, USD Million, 2018 - 2030)
Plasmid DNA Manufacturing Market - Application Scope Outlook (Revenue, USD Million, 2018 - 2030)
Plasmid DNA Manufacturing Market - Disease Scope Outlook (Revenue, USD Million, 2018 - 2030)
Plasmid DNA Manufacturing Market - Regional Scope Outlook (Revenue, USD Million, 2018 - 2030)
List of Key Players of Plasmid DNA Manufacturing Market
Check out more related studies published by Grand View Research:
Browse through Grand View Research's Biotechnology Industry Research Reports.
About Grand View Research
Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.
Copyright 2022 PR Newswire Association LLC.
|Back to overview list|